Inhaled Nitric Oxide Market to Grow with a CAGR of 7.12% through 2030
Growing neonatal
respiratory disorders is expected to drive the Global Inhaled Nitric Oxide
Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Inhaled Nitric Oxide Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Inhaled Nitric Oxide Market stood at USD 732.12 million in 2024 and
is anticipated to grow with a CAGR of 7.12% in the forecast period, 2026-2030. One
of the primary drivers fueling the growth of the global inhaled nitric oxide
market is the rising prevalence of respiratory disorders. Conditions such as
chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory
distress syndrome (ARDS) have witnessed a surge in incidence globally. Inhaled
nitric oxide, with its vasodilatory and anti-inflammatory properties, has
emerged as a crucial therapeutic option for managing these respiratory
conditions. As the burden of respiratory diseases continues to escalate, the
demand for effective and targeted treatments, including inhaled nitric oxide,
is expected to rise, propelling market growth.
The application
of inhaled nitric oxide in neonatology is another significant driver shaping
the market landscape. Neonatal care has witnessed a paradigm shift with the
adoption of inhaled nitric oxide for treating persistent pulmonary hypertension
in newborns. This life-threatening condition can lead to significant morbidity
and mortality if left untreated. Inhaled nitric oxide acts as a selective
pulmonary vasodilator, improving oxygenation and reducing the need for more
invasive interventions. The expanding use of inhaled nitric oxide in neonatal
care is a critical driver for market growth, as healthcare providers
increasingly recognize its efficacy in improving outcomes for newborns.
The
ongoing research and development activities in the field of inhaled nitric
oxide contribute substantially to market expansion. Pharmaceutical companies
are investing heavily in exploring novel applications and formulations to
broaden the therapeutic scope of inhaled nitric oxide. Clinical trials are
underway to assess its effectiveness in addressing conditions beyond
respiratory disorders, including its potential application in cardiovascular
diseases. The dynamic nature of these research initiatives fosters innovation,
with the aim of improving patient outcomes and expanding the market's reach.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Inhaled Nitric Oxide Market”
The Global
Inhaled Nitric Oxide Market is segmented into Product Type, Application, Regional and Company.
Based
on the Application, Neonatal Respiratory Treatment emerged as the dominant
segment in the global market for Global Inhaled Nitric Oxide Market in
2024. The widespread adoption of inhaled
nitric oxide in neonatal care is driven by its efficacy in improving outcomes
for infants with respiratory distress syndrome and persistent pulmonary
hypertension. It provides a non-invasive and relatively safe intervention
compared to more invasive treatments, making it particularly suitable for the
fragile and vulnerable neonatal population. The neonatal respiratory
application of inhaled nitric oxide aligns with the global emphasis on
improving neonatal healthcare and reducing neonatal mortality rates. As
healthcare systems worldwide focus on enhancing perinatal care, the demand for
effective interventions such as inhaled nitric oxide in neonatal respiratory
treatment continues to grow. Inhaled nitric oxide acts as a selective pulmonary
vasodilator, helping to relax blood vessels in the lungs and improve oxygenation.
This targeted therapeutic approach is crucial in treating persistent pulmonary
hypertension, which can lead to hypoxemia and compromise the overall health of
newborns.
Major companies
operating in Global Inhaled Nitric Oxide Market are:
- Linde PLC
- Air Liquide Healthcare
- BOC Healthcare
- Matheson Tri-Gas Inc.
- Merck KGaA
- Mallinckrodt Pharmaceuticals (Novoteris)
- Nu-Med Plus Inc.
- Perma Pure LLC
- Praxair Distribution Inc.
- HALMA PLC
Download Free Sample Report
Customers can
also request for 10% free customization
on this report
“The
Global Inhaled Nitric Oxide Market is poised for robust growth in the coming
years. The rising prevalence of respiratory disorders, including chronic
obstructive pulmonary disease (COPD) and asthma, is expected to fuel the demand
for inhaled nitric oxide therapies. The expanding applications of
iNO in neonatal care, acute respiratory distress syndrome, and beyond, as
evidenced by ongoing research, are broadening its therapeutic scope. The global
healthcare landscape's continued focus on personalized medicine and precision
therapeutics aligns favorably with inhaled nitric oxide's versatility,
contributing to its widespread adoption. Advancements in drug
delivery systems and the integration of telehealth and remote patient monitoring
are enhancing the accessibility and efficiency of iNO treatments”. said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Inhaled Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Gas, Delivery Systems), By Application (Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, Other Applications), By Region and Competition 2020-2030F”, has evaluated
the future growth potential of Global Inhaled Nitric Oxide Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Inhaled Nitric Oxide Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com